Form 4: IGM Biosciences CFO Sells Shares to Cover Tax Obligations

IGM Biosciences CFO Misbah Tahir sold 7,329 shares of common stock on March 14, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 14, 2025, Misbah Tahir, the CFO of IGM Biosciences, Inc., sold 7,329 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at prices ranging from $1.19 to $1.28, with a weighted average sale price of $1.23.
• Following the transaction, Tahir directly owns 180,324 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by a company executive, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of insider trading activity and are required by the SEC to provide transparency into the transactions of company executives and directors. This sale appears to be related to tax obligations, which is a common reason for such transactions.

Stakeholder Impact

• The sale of shares by the CFO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates